FibroGen Inc
NASDAQ:KYNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
Cabot Corp
NYSE:CBT
|
US |
|
Sandvik AB
F:SVK
|
SE |
|
Mavi Giyim Sanayi ve Ticaret AS
IST:MAVI.E
|
TR |
|
Aura Biosciences Inc
NASDAQ:AURA
|
US |
|
T
|
Thor Industries Inc
F:TIV
|
US |
|
C
|
Cencora Inc
XMUN:ABG
|
US |
|
Singapore Airlines Ltd
F:SIA1
|
SG |
|
A
|
Abercrombie & Fitch Co
DUS:AFT
|
US |
|
N
|
Novo Nordisk A/S
DUS:NOV
|
DK |
|
N
|
National Grid PLC
XMUN:NNGF
|
UK |
|
A
|
Anheuser-Busch Inbev SA
VSE:ABIN
|
BE |
|
Alliance Integrated Metaliks Ltd
BSE:534064
|
IN |
|
T
|
Timken India Ltd
NSE:TIMKEN
|
IN |
|
J
|
Johnson & Johnson
SWB:JNJ
|
US |
|
Nel ASA
LSE:0E4Q
|
NO |
|
P
|
Pultegroup Inc
XMUN:PU7
|
US |
|
Q
|
Qube Holdings Ltd
F:1K1
|
AU |
|
N
|
Northern Star Resources Ltd
XBER:NS7
|
AU |
|
Imperial Oil Ltd
TSX:IMO
|
CA |
|
T
|
Toyota Motor Corp
DUS:TOM
|
JP |
|
Infineon Technologies AG
OTC:IFNNF
|
DE |
|
C
|
Central Japan Railway Co
SWB:JAP
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KYNB's stock price target?
Not Available
KYNB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for FibroGen Inc?
Projected CAGR
-32%
Over the last 11 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 4 years is -32%.